Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BHMT | Q93088 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5188914 | 0.97 | TDP1 (0.42) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL7780055 | 0.80 | TDP1 (0.40) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL8948260 | 0.79 | TDP1 (0.50) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL17372820 | 0.78 | CA2 (0.36) | TDP1CPB1SMN1; SMN2SLC22A6NPSR1 | |
| SCHEMBL630577 | 0.78 | TDP1 (0.48) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL10729283 | 0.78 | TDP1 (0.48) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL7720554 | 0.76 | TDP1 (0.46) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| Hydrogen Sulfide SCHEMBL11546403 | 0.76 | TDP1 (0.46) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL233153 | 0.75 | TDP1 (0.40) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 | |
| SCHEMBL630522 | 0.75 | SMN1; SMN2 (0.44) | TDP1CPB1SMN1; SMN2SLC22A6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2553 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3829569-B1 | SPINOSYN FORMULATIONS FOR USE IN THE TREATMENT OF DEMODEX-INDUCED OCULAR CONDITIONS | APERTA BIOSCIENCES LLC (US) | 2025-09-03 | — | — | EP | claimed |
| US-12337065-B2 | Compositions for treating viral infections and methods for same | ACCESS TO ADVANCED HEALTH INSTITUTE (US) | 2025-06-24 | — | — | US | claimed |
| US-12297294-B2 | Cortistatin analogues for the treatment of inflammatory and/or immune diseases | BCN PEPTIDES, S.A. (ES) | 2025-05-13 | — | — | US | claimed |
| EP-4543898-A1 | PYRIMIDINE NUCLEOSIDE TREATMENTS | The Children's Medical Center Corporation (US) | 2025-04-30 | — | — | EP | claimed |
| EP-4365189-B1 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | HOFFMANN LA ROCHE (CH) | 2025-02-19 | — | — | EP | claimed |
| EP-4365189-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | GENENTECH, INC. (US) | 2024-05-08 | — | — | EP | claimed |
| EP-4335863-A2 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| US-20240075047-A1 | aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2024-03-07 | — | — | US | claimed |
| EP-4245766-A9 | PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | Genentech, Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| US-11865125-B2 | APKC inhibitors and methods of treating a neurodegenerative disease or disorder | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-01-09 | — | — | US | claimed |
| WO-2005123193-A2 | TREATMENTS COMPRISING STRONTIUM FOR RHEUMATIC AND ARTHRITIC DISEASES AND PAIN | OSTEOLOGIX A/S (DK) | 2005-12-29 | — | — | WO | claimed |
| WO-2005108339-A2 | HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS | OSTEOLOGIX A/S (DK) | 2005-11-17 | — | — | WO | claimed |
| US-6914128-B1 | Comprises immunoglobulin for treatment and prevention of inflammatory and autoimmune diseases | ABBOTT GMBH & CO. KG (DE) | 2005-07-05 | — | — | US | claimed |
| WO-2004045505-A2 | EXTRACT OF STEPHANIAE SINICA DIELS AND METHODS OF USING THE SAME | WONG KIN-PING (US) | 2004-06-03 | — | — | WO | claimed |
| WO-2004043346-A2 | COMPOSITIONS CONTAINING AN ACTIVE FRACTION ISOLATED FROM LYCIUM BARBARUM AND METHODS OF USING THE SAME | WONG KIN-PING (US) | 2004-05-27 | — | — | WO | claimed |
| WO-2001021190-A9 | TREATMENT FOR NARCOLEPSY | UNIV CALIFORNIA (US) | 2002-07-11 | — | — | WO | claimed |
| WO-2001021190-A1 | TREATMENT FOR NARCOLEPSY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-03-29 | — | — | WO | claimed |
| US-6204245-B1 | Treatment of narcolepsy with immunosuppressants | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-03-20 | — | — | US | claimed |
| EP-0427843-B1 | SPECIFIC INHIBITOR FOR RETROVIRUS REVERSE TRANSCRIPTASE, AND ITS APPLICATION AS A MEDICAMENT | BLOUGH HERBERT A (US) | 1995-03-08 | — | — | EP | claimed |
| US-4265823-A | GOLD COMPOUNDS POSSESSING ANTIINFLAMMATORY PROPERTIES | Kosinski, Robert E. (US) | 1981-05-05 | — | — | US | claimed |